Details for New Drug Application (NDA): 205295
✉ Email this page to a colleague
The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
Summary for 205295
Tradename: | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE |
Applicant: | Fdc Ltd |
Ingredient: | dorzolamide hydrochloride; timolol maleate |
Patents: | 0 |
Pharmacology for NDA: 205295
Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
Suppliers and Packaging for NDA: 205295
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 205295 | ANDA | Leading Pharma, LLC | 69315-305 | 69315-305-05 | 1 BOTTLE, PLASTIC in 1 CARTON (69315-305-05) / 5 mL in 1 BOTTLE, PLASTIC |
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 205295 | ANDA | Leading Pharma, LLC | 69315-305 | 69315-305-10 | 1 BOTTLE, PLASTIC in 1 CARTON (69315-305-10) / 10 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 2% BASE;EQ 0.5% BASE | ||||
Approval Date: | Jun 13, 2019 | TE: | AT1 | RLD: | No |
Complete Access Available with Subscription